Delaware Top Court Sides With Zantac Makers in Cancer Claims July 11, 2025 By Jef Feeley The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major...
GSK Agrees to Settle About 80,000 Zantac Lawsuits for Up to $2.2B October 10, 2024 By Brendan Pierson GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a...
Judge Lets More Than 70,000 Zantac Lawsuits Go Forward June 4, 2024 By Brendan Pierson A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert...
Pfizer Agrees to Settle More Than 10,000 Zantac Cancer Lawsuits May 8, 2024 By Jef Feeley Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac...
Sanofi to Settle 4,000 Zantac Cancer Lawsuits in US State Courts April 4, 2024 By Dietrich Knauth Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer,...
Fate of Most Remaining Zantac Lawsuits Weighed by Delaware Judge January 26, 2024 By Brendan Pierson GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs’ lawyers...
Appeals Court Dismisses a Third-Party Payer Class Action in Win for Zantac Makers November 10, 2022 By Insurance Journal Staff Reports Reports about the risk of carcinogens in Zantac heartburn medications may be piling up, and lawsuits over the discontinued drug...